AU2001258121A1 - Ph domain-interacting protein - Google Patents
Ph domain-interacting proteinInfo
- Publication number
- AU2001258121A1 AU2001258121A1 AU2001258121A AU5812101A AU2001258121A1 AU 2001258121 A1 AU2001258121 A1 AU 2001258121A1 AU 2001258121 A AU2001258121 A AU 2001258121A AU 5812101 A AU5812101 A AU 5812101A AU 2001258121 A1 AU2001258121 A1 AU 2001258121A1
- Authority
- AU
- Australia
- Prior art keywords
- domain
- interacting protein
- interacting
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20356100P | 2000-05-11 | 2000-05-11 | |
| US60/203,561 | 2000-05-11 | ||
| PCT/CA2001/000673 WO2001085785A2 (fr) | 2000-05-11 | 2001-05-10 | Proteine d'interaction avec le domaine ph |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001258121A1 true AU2001258121A1 (en) | 2001-11-20 |
Family
ID=22754481
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001258121A Abandoned AU2001258121A1 (en) | 2000-05-11 | 2001-05-10 | Ph domain-interacting protein |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20040086863A1 (fr) |
| EP (1) | EP1280903A2 (fr) |
| JP (1) | JP2004524802A (fr) |
| AU (1) | AU2001258121A1 (fr) |
| CA (1) | CA2408632A1 (fr) |
| WO (1) | WO2001085785A2 (fr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090068110A1 (en) * | 2006-12-22 | 2009-03-12 | Genentech, Inc. | Antibodies to insulin-like growth factor receptor |
| US20100316639A1 (en) | 2009-06-16 | 2010-12-16 | Genentech, Inc. | Biomarkers for igf-1r inhibitor therapy |
| CN113049824A (zh) * | 2021-04-20 | 2021-06-29 | 首都医科大学附属北京妇产医院 | 载脂蛋白ApoA1在宫颈癌对铂类化疗耐药检测中的应用 |
| CN117980479A (zh) * | 2021-06-21 | 2024-05-03 | 斯托克制药公司 | 用于治疗基于无义介导的rna衰变的病状和疾病的反义寡聚体 |
| CN115998883B (zh) * | 2023-03-21 | 2023-09-12 | 中国医学科学院基础医学研究所 | Cflar的抑制剂在治疗arid1a缺失型肿瘤中的应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1297916A (zh) * | 1999-11-26 | 2001-06-06 | 上海博容基因开发有限公司 | 一种新的多肽——人含溴基结构域的蛋白95和编码这种多肽的多核苷酸 |
| AU2001243642A1 (en) * | 2000-03-13 | 2001-10-08 | Incyte Genomics, Inc. | Transcription factors |
-
2001
- 2001-05-10 WO PCT/CA2001/000673 patent/WO2001085785A2/fr not_active Ceased
- 2001-05-10 CA CA002408632A patent/CA2408632A1/fr not_active Abandoned
- 2001-05-10 AU AU2001258121A patent/AU2001258121A1/en not_active Abandoned
- 2001-05-10 US US10/275,762 patent/US20040086863A1/en not_active Abandoned
- 2001-05-10 EP EP01931293A patent/EP1280903A2/fr not_active Withdrawn
- 2001-05-10 JP JP2001582384A patent/JP2004524802A/ja active Pending
-
2008
- 2008-03-12 US US12/046,953 patent/US20080241147A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1280903A2 (fr) | 2003-02-05 |
| WO2001085785A3 (fr) | 2002-09-06 |
| US20080241147A1 (en) | 2008-10-02 |
| US20040086863A1 (en) | 2004-05-06 |
| CA2408632A1 (fr) | 2001-11-15 |
| JP2004524802A (ja) | 2004-08-19 |
| WO2001085785A2 (fr) | 2001-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001269836A1 (en) | Proteases | |
| AU2001273164A1 (en) | Membrane associated protein zupari | |
| AU2001272651A1 (en) | Valves | |
| AU2001242625A1 (en) | Gene sequence | |
| AU2002239753A1 (en) | Proteases | |
| AU2001269888A1 (en) | Protein phosphatases | |
| AU2001247483A1 (en) | Proteases | |
| AU2001283012A1 (en) | Protein phosphatases | |
| AU2001274566A1 (en) | Novel protein and dna thereof | |
| AU2001264247A1 (en) | GASC1 gene | |
| AU2001258121A1 (en) | Ph domain-interacting protein | |
| AU2001292870A1 (en) | Protein phosphatases | |
| AU2472501A (en) | Methods for protein transfer | |
| AU2001292594A1 (en) | Proteases | |
| AU2001244863A1 (en) | Apoptin-associating protein | |
| AU2001285743A1 (en) | Adipose-related gene | |
| AU2001294823A1 (en) | Hydrolases | |
| AU2002239747A1 (en) | Cystoskeleton-associated proteins | |
| AU2001262589A1 (en) | Glycosyltransferase proteins | |
| AU2001253701A1 (en) | A memory enhancing protein | |
| AU2001259240A1 (en) | Novel stmst protein and nucleic acid mocecules and uses therefor | |
| AU2001259565A1 (en) | Proteases | |
| AU2002236595A1 (en) | Enzymes | |
| AU2001278777A1 (en) | Irap-binding protein | |
| AU2001241044A1 (en) | Mitf-associated proteins |